| __timestamp | Axsome Therapeutics, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 84580000 |
| Thursday, January 1, 2015 | 6776987 | 86943000 |
| Friday, January 1, 2016 | 21199860 | 84493000 |
| Sunday, January 1, 2017 | 19957616 | 64988000 |
| Monday, January 1, 2018 | 23495055 | 74951000 |
| Tuesday, January 1, 2019 | 53647067 | 62331000 |
| Wednesday, January 1, 2020 | 70244579 | 28607000 |
| Friday, January 1, 2021 | 58060725 | 32228000 |
| Saturday, January 1, 2022 | 57947447 | 46600000 |
| Sunday, January 1, 2023 | 97944000 | 54886000 |
| Monday, January 1, 2024 | 187077000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Axsome Therapeutics, Inc. and Dynavax Technologies Corporation have demonstrated contrasting R&D investment strategies.
From 2014 to 2023, Axsome Therapeutics increased its R&D expenses by over 2,000%, peaking in 2023 with a remarkable 98 million dollars. This surge underscores Axsome's aggressive pursuit of new therapeutic solutions. In contrast, Dynavax Technologies, while maintaining a robust R&D budget, saw a 35% decrease from its 2014 peak of 85 million dollars to 55 million dollars in 2023. This shift may reflect a strategic pivot or a focus on optimizing existing products.
These trends highlight the dynamic nature of biotech investments, where strategic R&D spending can significantly influence a company's trajectory and market position.
R&D Spending Showdown: Vertex Pharmaceuticals Incorporated vs Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Dynavax Technologies Corporation
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc.
R&D Insights: How Halozyme Therapeutics, Inc. and Dynavax Technologies Corporation Allocate Funds
Research and Development Investment: Corcept Therapeutics Incorporated vs Dynavax Technologies Corporation
Comparing Innovation Spending: Axsome Therapeutics, Inc. and PTC Therapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Axsome Therapeutics, Inc. vs Xencor, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Novavax, Inc.
Rhythm Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and Dynavax Technologies Corporation